"10.1371_journal.pone.0083400","plos one","2014-01-08T00:00:00Z","Marika Pane; Elena S Mazzone; Maria Pia Sormani; Sonia Messina; Gian Luca Vita; Lavinia Fanelli; Angela Berardinelli; Yvan Torrente; Adele D'Amico; Valentina Lanzillotta; Emanuela Viggiano; Paola D'Ambrosio; Filippo Cavallaro; Silvia Frosini; Luca Bello; Serena Bonfiglio; Roberta Scalise; Roberto De Sanctis; Enrica Rolle; Flaviana Bianco; Marlene Van der Haawue; Francesca Magri; Concetta Palermo; Francesca Rossi; Maria Alice Donati; Chiara Alfonsi; Michele Sacchini; Maria Teresa Arnoldi; Giovanni Baranello; Tiziana Mongini; Antonella Pini; Roberta Battini; Elena Pegoraro; Stefano C Previtali; Sara Napolitano; Claudio Bruno; Luisa Politano; Giacomo P Comi; Enrico Bertini; Lucia Morandi; Francesca Gualandi; Alessandra Ferlini; Nathalie Goemans; Eugenio Mercuri","Department of Paediatric Neurology, Catholic University, Rome, Italy; Biostatistics Unit, Department of Health Sciences, University of Genoa, Italy; Department of Neurosciences, Psychiatry and Anaesthesiology, University of Messina, Messina, Italy; Child Neurology and Psychiatry Unit, C. Mondino Foundation, Pavia, Italy; Dino Ferrari Centre, Neuroscience Section, Department of Pathophysiology and Transplantation (DEPT), University of Milan, Neurology Unit, Ca Granda Ospedale Maggiore Policlinico, Milan, Italy; Unit of Neuromuscular and Neurodegenerative Diseases, Department of Neurosciences, Bambino Gesù Childrens Hospital, Rome, Italy; Neuromuscular Disease Unit, G. Gaslini Institute, Genoa, Italy; Dipartimento di Medicina Sperimentale, Seconda Università di Napoli, Napoli, Italy; Department of Developmental Neuroscience, Stella Maris Institute, University of Pisa, Pisa, Italy; Department of Neurosciences, University of Padua, Padua, Italy; Child Neurology and Psychiatry Unit, IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy; Neuromuscular Center, SG. Battista Hospital, University of Turin, Turin, Italy; Pediatric Neurology KU Gasthuisberg, Leuven, Belgium; Metabolic and Neuromuscular Unit, Meyer Hospital, Florence, Italy; Developmental Neurology Unit, Istituto Neurologico Besta, Milan, Italy; Department of Neurology, San Raffaele Scientific Institute, Milan, Italy; Neuromuscular Disease and Immunology Unit, Istituto Neurologico Besta, Milan, Italy; Section of Medical Genetics, Department of Experimental and Diagnostic Medicine, University of Ferrara, Ferrara, Italy","Conceived and designed the experiments: MP ESM MPS EB AF NG EM. erformed the experiments: ESM LF VL FC SF RD ER FR. Analyzed the data: MP ESM MPS SM GLV AB YT AD EV PD LB SB RS FB MVDH FM CP MAD MS MTA GB TM AP RB EP SCP SN CB LP GPC EB LM FG AF NG EM. Contributed reagents/materials/analysis tools: MP ESM MPS SM GLV AB YT AD EV PD LB SB RS FB MVDH FM CP MADMS MTA GB TM AP RB EP SCP SN CB LP GPC EB LM FG AF NG EM. Wrote the manuscript: MP ESM MPS AF NG EM.","Dr. Pane, E. Mazzone report no disclosures. Dr. Sormani: serves on a scientific advisory board for Biogen Idec. has received funding for travel or speaker honoraria from Merck Serono; serves as consultant for Merck Serono, Actelion Pharmaceuticals Lts. Biogen Idec, and Synthon; and serves on the speakers bureaus of Teva Pharmaceutical Industries Ltd., Merck Serono, and Biogen Idec. Dr. Messina reports no disclosures. Dr.Vita serves a san Associate Editor for Neurological Sciences. L. Fanelli, Dr. Berardinelli, Dr. Torrente, Dr. DAmico, V. Lanzillotta, Dr. Viggiano, Dr. DAmbrosio, F. Cavallaro, S. Frosini, Dr. Bello, Dr. Bonfiglio, Dr. Scalise, R. De Sanctis, E. Rolle, Dr. Bianco, Dr. Van der Haawue, Dr. Magri, Dr. Palermo, F. Rossi, Dr. Donati, Dr. Sacchini, Dr. Arnoldi, Dr Baranello report no disclosures. Dr. Mongini has received funding for travel from Genzyme Corporation. Dr. Pini, Dr. Battini report no disclosures. Dr. Pegoraro has served on a scientific advisory board for BioMarin Pharmaceutical Inc.; has received funding for travel from Genzyme Corporation; and has received speaker honoraria from MedaPharma. Dr. Previtali, Dr. Bruno, Dr. Napolitano, Dr. Politano report no disclosures. Dr. Comi: is site PI for the PTC extension study of Ataluren in DMD and for the GSK study on exon skipping. Dr. Bertini is site PI for the PTC extension study of Ataluren in DMD, for the GSK study on exon skipping. Dr. L. Morandi, Dr. F. Gualandi, Dr. A. Ferlini, Dr. N. Goemans reports no discorures, Dr. Mercuri is site PI for the PTC extension study of Ataluren in DMD,for the GSK study on exon skipping. He has acted as advisory board for Acceleron Pharma, Shire and PTC Therapeutics, Inc./Genzyme Corporation. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2014","01","Marika Pane","MP",44,TRUE,7,NA,36,6,TRUE,TRUE,TRUE,1,"26",FALSE
